Literature DB >> 28863444

Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?

Siddhant Datta1, Edward E Walsh1,2, Derick R Peterson3, Ann R Falsey1,2.   

Abstract

Respiratory syncytial virus (RSV) is increasingly recognized as a significant cause of adult respiratory illness. We evaluated routine viral testing and discharge diagnoses for identifying RSV and influenza burden. Polymerase chain reaction results performed in adults during emergency room visits or hospitalizations were reviewed. Peak RSV activity preceded influenza activity by 8 weeks. The ratio of total number of viral tests performed divided by total number of respiratory visits was higher during influenza than RSV peaks (1.31 vs 0.72; P = .0001). Influenza and RSV were listed primary diagnoses in 56 (30%) vs 7 (6%), respectively (P < .0001). Routine viral testing to estimate adult RSV disease burden has limitations.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  RSV; disease burden; influenza; viral activity

Mesh:

Year:  2017        PMID: 28863444     DOI: 10.1093/infdis/jix196

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Respiratory Virus Infection During Pregnancy: Does It Matter?

Authors:  Janet A Englund; Helen Y Chu
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

2.  Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure.

Authors:  Ann R Falsey; Edward E Walsh; Mark T Esser; Kathryn Shoemaker; Li Yu; M Pam Griffin
Journal:  J Med Virol       Date:  2018-09-24       Impact factor: 2.327

Review 3.  Respiratory viral infections in the elderly.

Authors:  Alastair Watson; Tom M A Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

4.  Respiratory syncytial virus-associated deaths in the United States according to death certificate data, 2005 to 2016.

Authors:  Mila M Prill; Gayle E Langley; Amber Winn; Susan I Gerber
Journal:  Health Sci Rep       Date:  2021-11-02

5.  Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis.

Authors:  John M McLaughlin; Farid Khan; Elizabeth Begier; David L Swerdlow; Luis Jodar; Ann R Falsey
Journal:  Open Forum Infect Dis       Date:  2022-06-17       Impact factor: 4.423

6.  Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults.

Authors:  Jin Gu Yoon; Ji Yun Noh; Won Suk Choi; Jin Ju Park; Yoo Bin Suh; Joon Young Song; Hee Jin Cheong; Woo Joo Kim
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

7.  Microorganisms associated with respiratory syncytial virus pneumonia in the adult population.

Authors:  M Jeannoël; G Lina; J P Rasigade; B Lina; F Morfin; Jean Sebastien Casalegno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-23       Impact factor: 3.267

8.  Evaluation of the ImmuView RSV Test for Rapid Detection of Respiratory Syncytial Virus in Adult Patients with Influenza-Like Symptoms.

Authors:  E Larsson; S Johansson; O Frøbert; A Nordenskjöld; S Athlin
Journal:  Microbiol Spectr       Date:  2021-12-08

9.  Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017-2019.

Authors:  Yoonyoung Choi; Alexandra Hill-Ricciuti; Angela R Branche; William D Sieling; Lisa Saiman; Edward E Walsh; Matthew Phillips; Ann R Falsey; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2021-10-03       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.